| Financial Year |
March 31 2023 |
| Monetary Funds |
2,086,131,709.14 |
| Held-for-trading Financial Assets |
411,050,831.26 |
| Notes Receivable |
3,676,463.94 |
| Accounts Receivable |
3,496,877,630.40 |
| Advances to Suppliers |
128,275,343.17 |
| Other Receivables |
64,882,867.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
418,524,988.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
120,298,511.44 |
| Other Current Assets |
719,463,998.29 |
| Total Current Assets |
7,680,206,425.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
62,759,130.26 |
| Long-term Equity Investment |
994,244,376.84 |
| Investment Properties |
21,376,228.34 |
| Fixed Assetes |
1,200,769,823.63 |
| Under-construction Projects |
631,583,904.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
216,010,953.50 |
| R&D expenses |
580,908,025.96 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
46,799,056.41 |
| Deferred Income Tax Assets |
201,537,319.12 |
| Other Non-Current Assets |
1,506,812,768.80 |
| Sub-Total of Non-Current Assets |
6,154,864,553.82 |
| Total Assets |
13,835,070,979.37 |
| Short-Term Loans |
84,711,850.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
610,577,957.81 |
| Accounts Received In Advance |
16,887,740.84 |
| Employee Compensation Payable |
843,609,559.60 |
| Taxes Payable |
200,266,805.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
154,654,811.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,842,434.14 |
| Other Current Liabilities |
2,176,235.84 |
| Sub-Total of Current Liabilities |
2,045,069,638.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,858,883.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
20,055,240.69 |
| Deferred Income Tax Liabilities |
54,083,642.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
136,684,654.18 |
| Total Liabilities |
2,181,754,292.59 |
| Paid-In Capital(Or Share Stock) |
1,403,446,032.00 |
| Capital Surplus |
719,989,645.48 |
| Surplus Reserve |
1,250,174,329.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,966,922,362.17 |
| Minority Stockholder's Interest |
315,895,730.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,337,420,956.39 |
| Owner's Equity（Stockholder's Equity） |
11,653,316,686.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,835,070,979.37 |
